Mersana Therapeutics saw the highest growth of 249% in patent filings and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 249% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of Mersana Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Mersana Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with five publications in Q4 2023

The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 17% filings and 50% grants. The United States(US), European Patent Office(EPO), Argentina(AR), and Brazil(BR) patent Office are among the top ten patent offices where Mersana Therapeutics is filings its patents. Among the top granted patent authorities, Mersana Therapeutics has 50% of its grants in European Patent Office(EPO) and 25% in United States(US).

Patents related to rare diseases and nanomedicine lead Mersana Therapeutics's portfolio

Mersana Therapeutics has the highest number of patents in rare diseases followed by, nanomedicine and precision and personalized medicine. For rare diseases, nearly 50% of patents were filed and 100% of patents were granted in Q4 2023.

Ovarian cancer related patents lead Mersana Therapeutics portfolio followed by breast cancer, and non-small cell lung cancer

Mersana Therapeutics has highest number of patents in ovarian cancer followed by breast cancer, non-small cell lung cancer, colorectal tumor, and papillary thyroid cancer. For ovarian cancer, nearly 6% of patents were filed and 7% of patents were granted in Q4 2023.

For comprehensive analysis of Mersana Therapeutics's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.